HIV env 816-825 (HLA-A*02:01)
( SLLNATAIAV )
Correlation between HLA class I and spontaneous control of HIV-1 was significant for 7-8 epitopes when 341 chronic, HIV-infected subjects, divided into controllers and non-controllers, were tested for EliSpot responses to 257 optimally defined epitopes. 21 epitopes were associated with viral progression. Protective epitopes tend to cluster in regions of critical stability for the protein, therefore constraining escape. SLLNATAIAV had a significantly positive association with HLA A*02; it was recognized by 23/134 A*02-positive subjects and 9/190 A*02-negative subjects.
| Sequence: | SLLNATAIAV | |
| Gene: | env | |
| Delivery: | 2-3 days | |
| C-Terminus: | OH | |
| N-Terminus: | H | |
| Amount: | 1 mg | |
| Counter Ion: | TFA | |
| Protein: | Envelope glycoprotein gp160 | |
| Species: | HIV | |
| Allele: | HLA-A*02:01 | |
| Application : | Flow Cytometry Immunohistochemistry | |
| Indication : | AIDS (HIV) | |
| Purity : | 95% HPLC-MS |
Protocols and Tips
Data sheets
Safety data sheet poly peptides:
Special references for this product will come soon.
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
€60.40*
Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Product number:
EP11243_1